Cargando…
Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma
BACKGROUND: Fibroblast growth factors FGF-1 and FGF-2 are often upregulated in tumors, but tightly bound to heparan sulphate proteoglycans of the extracellular matrix (ECM). One mechanism of their bioactivation relies on the FGF-binding protein (FGF-BP) which, upon reversible binding to FGF-1 or -2,...
Autores principales: | Schulze, Daniel, Plohmann, Philipp, Höbel, Sabrina, Aigner, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281803/ https://www.ncbi.nlm.nih.gov/pubmed/22111880 http://dx.doi.org/10.1186/1476-4598-10-144 |
Ejemplares similares
-
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
por: Höbel, Sabrina, et al.
Publicado: (2011) -
PKC regulates the production of fibroblast growth factor 23 (FGF23)
por: Bär, Ludmilla, et al.
Publicado: (2019) -
Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2
Publicado: (1996) -
Ghrelin Ameliorates Traumatic Brain Injury by Down-Regulating bFGF and FGF-BP
por: Shao, Xuefei, et al.
Publicado: (2018) -
Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23)
por: Feger, Martina, et al.
Publicado: (2021)